Placenta Growth Factor
-
Subject Areas on Research
- Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells.
- Angiokines Associated with Targeted Therapy Outcomes in Patients with Non-Clear Cell Renal Cell Carcinoma.
- Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma.
- Augmentation of transvascular transport of macromolecules and nanoparticles in tumors using vascular endothelial growth factor.
- Circulating angiogenic factors and abnormal uterine artery Doppler velocimetry in the second trimester.
- Circulating levels of the antiangiogenic marker sFLT-1 are increased in first versus second pregnancies.
- Early-pregnancy prediction of risk for pre-eclampsia using maternal blood leptin/ceramide ratio: discovery and confirmation.
- Enhanced HIF2α expression during human trophoblast differentiation into syncytiotrophoblast suppresses transcription of placental growth factor.
- Exposure to perfluorobutane sulfonate and perfluorooctanesulfonic acid disrupts the production of angiogenesis factors and stress responses in human placental syncytiotrophoblast.
- First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.
- Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia.
- Placenta growth factor in sickle cell disease: association with hemolysis and inflammation.
- Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease.
- Preeclampsia: animal models for a human cure.
- The effect of cigarette smoke extract on trophoblast cell viability and migration: the role of adrenomedullin.
- Vascular tissues are a primary source of BMP2 expression during bone formation induced by distraction osteogenesis.